ArticleCancer research communications2024

Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer.

Jonathan Goldberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.